neominophagen c has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, G | 1 |
| Iwabuchi, S; Osada, T; Takatori, M; Yoshida, H | 1 |
2 review(s) available for neominophagen c and Cirrhosis, Liver
| Article | Year |
|---|---|
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].
Topics: Biomarkers; Cysteine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Middle Aged; Oleanolic Acid; RNA, Viral | 1994 |